(EWBC) East West Bancorp - Overview
Sector: Financial Services | Industry: Banks - Regional | Exchange: NASDAQ (USA) | Market Cap: 15.772m USD | Total Return: 55.3% in 12m
Loans, Deposits, Banking, Financing, Wealth Management
Total Rating 59
Safety 72
Buy Signal 0.94
Banks - Regional
Industry Rotation: +16.3
Industry Rotation: +16.3
Market Cap:
15.8B
Avg Turnover: 109M USD
Avg Turnover: 109M USD
ATR:
2.65%
Peers RS (IBD): 45.2
Peers RS (IBD): 45.2
Risk 5d forecast
Volatility29.3%
Rel. Tail Risk-6.28%
Reward TTM
Sharpe Ratio1.73
Alpha22.30
Character TTM
Beta1.218
Beta Downside1.759
Drawdowns 3y
Max DD35.77%
CAGR/Max DD0.93
EPS (Earnings per Share)
EPS CAGR: 11.77%
EPS Trend: 62.4%
EPS Trend: 62.4%
Last SUE: 0.24
Qual. Beats: 0
Qual. Beats: 0
Revenue
Rev. CAGR: 25.07%
Rev. Trend: 75.1%
Rev. Trend: 75.1%
Last SUE: 3.92
Qual. Beats: 4
Qual. Beats: 4
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Description: EWBC East West Bancorp
East West Bancorp, Inc. (EWBC) is a bank holding company operating East West Bank. It provides personal and commercial banking services in the United States.
The company operates through Consumer and Business Banking, Commercial Banking, and Other segments. Its offerings include diverse deposit products like checking, savings, money market, and time deposits. Regional banks, like East West Bank, typically focus on community-based financial services and local economic development.
EWBC offers a variety of loan products, including mortgage, commercial and residential real estate, construction, and commercial business loans. The bank also provides specialized financing for business transactions between the United States and Asia, a common strategy for banks targeting specific international trade corridors. Additional services include foreign exchange, treasury management, wealth management, and risk hedging.
For more detailed financial analysis, consider exploring ValueRay.
- Net interest margin compression impacts profitability
- Loan growth in commercial real estate drives revenue
- Regulatory changes in banking sector increase compliance costs
- Economic slowdown reduces loan demand
- US-Asia trade relations influence international banking services
Piotroski VR‑10 (Strict)
3.5
| Net Income: 1.33b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.01 > 1.0 |
| NWC/Revenue: -43.26% < 20% (prev -1.44k%; Δ 1.40k% < -1%) |
| CFO/TA 0.02 > 3% & CFO 1.50b > Net Income 1.33b |
| Net Debt (2.52b) to EBITDA (2.03b): 1.24 < 3 |
| Current Ratio: 0.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (139.1m) vs 12m ago -0.56% < -2% |
| Gross Margin: 60.10% > 18% (prev 0.48%; Δ 5.96k% > 0.5%) |
| Asset Turnover: 5.99% > 50% (prev 5.28%; Δ 0.72% > 0%) |
| Interest Coverage Ratio: 1.01 > 6 (EBITDA TTM 2.03b / Interest Expense TTM 1.74b) |
Altman Z''
0.44
| A: -0.03 (Total Current Assets 971.8m - Total Current Liabilities 3.00b) / Total Assets 80.43b |
| B: 0.10 (Retained Earnings 8.30b / Total Assets 80.43b) |
| C: 0.02 (EBIT TTM 1.76b / Avg Total Assets 78.21b) |
| D: 0.11 (Book Value of Equity 7.96b / Total Liabilities 71.54b) |
| Altman-Z'' Score: 0.44 = B |
What is the price of EWBC shares?
As of April 10, 2026, the stock is trading at USD 116.73 with a total of 847,289 shares traded.
Over the past week, the price has changed by +7.10%, over one month by +9.09%, over three months by +0.09% and over the past year by +55.26%.
Over the past week, the price has changed by +7.10%, over one month by +9.09%, over three months by +0.09% and over the past year by +55.26%.
Is EWBC a buy, sell or hold?
East West Bancorp has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy EWBC.
- StrongBuy: 5
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EWBC price?
| Analysts Target Price | 129.6 | 11.1% |
East West Bancorp (EWBC) - Fundamental Data Overview
as of 10 April 2026
P/E Trailing = 12.0378 P/E Forward = 14.9031
P/S = 5.8477
P/B = 1.6861
P/EG = 5.5751
Revenue TTM = 4.69b USD
EBIT TTM = 1.76b USD
EBITDA TTM = 2.03b USD
Long Term Debt = 3.04b USD (from longTermDebt, last quarter)
Short Term Debt = 3.00b USD (from shortTermDebt, last quarter)
Debt = 3.17b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.52b USD (from netDebt column, last quarter)
Enterprise Value = 18.29b USD (15.77b + Debt 3.17b - CCE 656.1m)
Interest Coverage Ratio = 1.01 (Ebit TTM 1.76b / Interest Expense TTM 1.74b)
EV/FCF = 12.18x (Enterprise Value 18.29b / FCF TTM 1.50b)
FCF Yield = 8.21% (FCF TTM 1.50b / Enterprise Value 18.29b)
FCF Margin = 32.03% (FCF TTM 1.50b / Revenue TTM 4.69b)
Net Margin = 28.27% (Net Income TTM 1.33b / Revenue TTM 4.69b)
Gross Margin = 60.10% ((Revenue TTM 4.69b - Cost of Revenue TTM 1.87b) / Revenue TTM)
Gross Margin QoQ = 64.63% (prev 61.10%)
Tobins Q-Ratio = 0.23 (Enterprise Value 18.29b / Total Assets 80.43b)
Interest Expense / Debt = 13.08% (Interest Expense 415.0m / Debt 3.17b)
Taxrate = 23.70% (110.7m / 466.9m)
NOPAT = 1.34b (EBIT 1.76b * (1 - 23.70%))
Current Ratio = 0.32 (Total Current Assets 971.8m / Total Current Liabilities 3.00b)
Debt / Equity = 0.36 (Debt 3.17b / totalStockholderEquity, last quarter 8.90b)
Debt / EBITDA = 1.24 (Net Debt 2.52b / EBITDA 2.03b)
Debt / FCF = 1.68 (Net Debt 2.52b / FCF TTM 1.50b)
Total Stockholder Equity = 8.40b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.69% (Net Income 1.33b / Total Assets 80.43b)
RoE = 15.77% (Net Income TTM 1.33b / Total Stockholder Equity 8.40b)
RoCE = 15.35% (EBIT 1.76b / Capital Employed (Equity 8.40b + L.T.Debt 3.04b))
RoIC = 11.46% (NOPAT 1.34b / Invested Capital 11.69b)
WACC = 10.22% (E(15.77b)/V(18.95b) * Re(10.27%) + D(3.17b)/V(18.95b) * Rd(13.08%) * (1-Tc(0.24)))
Discount Rate = 10.27% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.82%
[DCF] Terminal Value 70.23% ; FCFF base≈1.47b ; Y1≈1.43b ; Y5≈1.43b
[DCF] Fair Price = 111.8 (EV 17.91b - Net Debt 2.52b = Equity 15.39b / Shares 137.6m; r=10.22% [WACC]; 5y FCF grow -3.75% → 3.0% )
EPS Correlation: 62.36 | EPS CAGR: 11.77% | SUE: 0.24 | # QB: 0
Revenue Correlation: 75.12 | Revenue CAGR: 25.07% | SUE: 3.92 | # QB: 4
EPS next Quarter (2026-06-30): EPS=2.54 | Chg7d=+0.008 | Chg30d=+0.011 | Revisions Net=+0 | Analysts=15
EPS current Year (2026-12-31): EPS=10.28 | Chg7d=+0.013 | Chg30d=+0.018 | Revisions Net=-1 | Growth EPS=+8.3% | Growth Revenue=+6.1%
EPS next Year (2027-12-31): EPS=10.99 | Chg7d=+0.018 | Chg30d=+0.010 | Revisions Net=+1 | Growth EPS=+6.9% | Growth Revenue=+6.7%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.0% (Discount Rate 10.3% - Earnings Yield 8.3%)
[Growth] Growth Spread = +7.7% (Analyst 9.7% - Implied 2.0%)
External Resources